1643452

Terazosin -hydrochlorid

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): Terazosin -hydrochlorid Dihydrat, 1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-[(tetrahydro-2-furanyl)-carbonyl]-piperazin -hydrochlorid Dihydrat
• Empirische Formel (Hill-System): C₁₉H₂₅N₅O₄ · HCl · 2H₂O
• CAS-Nummer: 70024-40-7
• Molekulargewicht: 459.92
• MDL-Nummer: MFCD00941408
• UNSPSC-Code: 41116107
• PubChem Substanz-ID: 329751228
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: terazosin
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• SMILES String: O.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4
• InChI: 1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
• InChIKey: NZMOFYDMGFQZLS-UHFFFAOYSA-N
• Angaben zum Gen: human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146)

Beschreibung

Allgemeine Beschreibung

Terazosin hydrochloride is a quinazoline derivative. It is a alpha-1-selective adrenoceptor blocking agent. It has been used to treat hypertension, as it helps the blood vessels to relax, expand and improves blood flow.

Anwendung

Terazosin hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Terazosin Capsules
• Terazosin Tablets

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H319
• P-Sätze: P264 - P280 - P305 + P351 + P338 - P337 + P313
• Gefahreneinstufungen: Eye Irrit. 2
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable